Create Medic Co., Ltd.
Create Medic Co., Ltd. (JPX: 5187) is trading at ¥1,170.00, about ₹713 at today's JPY/INR rate, as of 28 Sep 2026, 2:30 AM ET, up 0.52% today. Indian residents can buy Create Medic from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥1,168.00
Today's high
¥1,192.00
52 week low
¥975.00
52 week high
¥1,244.00
5187 opened at ¥1,192.00, closed previously at ¥1,164.00, and has traded between ¥975.00 and ¥1,244.00 over the past 52 weeks.
About
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman, suprapubic, and nephrostomy balloon catheters, as well as self-catheterization set, all silicone self-catheter for replacement, pure-cath, nephrostomy kit, cystostomy set, and all silicone malecot catheter; and gastroenterology products, such as all silicone ileus, stomach, and sengstaken blakemore tubes, as well as transanal ileus decompression tube set. It also provides PEG products comprising PEG kit pull-method, with loop fixture, and bumper type, as well as CLINY introducer PEG kit, loop fixture II, all silicone gastrostomy balloon catheter for replacement, balloon button set, facil button for replacement, gastrostomy replacement catheter set, all silicone PEG J catheter, and transgastric jejunal balloon tube and guidewire set; surgery products, which include PTC drainage tube, PTCD kit, cholangio-entero tube, and internal external drainage catheter for PTCD; all silicone endotracheal and tracheostomy tubes and micro catheter; and OEM products. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
Key statistics
Avg. volume
10.61K
Market cap
¥9.56B
P/E Ratio
17.32
Price-to-sales ratio
0.68
Enterprise value
¥4.68B
Free cash flow yield
0.00%
Debt-to-equity ratio
0.05
Return on equity
3.47%
ROIC
2.66%
Beta
0.29
Dividend yield
4.10%
Last dividend
¥48.00
Financial overview
Revenue
¥13.62B
Earnings per share
¥84.25
Free cash flow
¥98.51M
Net profit margin
4.01%
Gross margin
41.82%
EBITDA
¥1.64B
Revenue growth
4.51%
Similar securities
This is not an investment recommendation
How to buy Create Medic from India
Indian residents can buy Create Medic shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Create Medic and place an order
Find Create Medic by name or by its ticker, 5187, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Create Medic trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Create Medic position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Create Medic from India
Trading and taxes when buying Create Medic from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Create Medic’s current yield is 4.10%.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Create Medic stock?
Yes. Create Medic (5187) has been listed on the Tokyo Stock Exchange since 2001, in the Medical - Specialties industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Create Medic share cost in rupees?
One Create Medic share is ¥1,170.00 — about ₹713 at a JPY/INR rate of 0.6091 on 27 Sep 2026. Both the Create Medic price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Create Medic from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Create Medic?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Create Medic shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Create Medic price. Paasa issues a capital-gains statement for your return.
Does Create Medic pay a dividend, and how is it taxed in India?
Yes. Create Medic pays a dividend and the current yield is 4.10%; the last declared dividend was ¥48.00 per share, about ₹29.24. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Create Medic from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Create Medic shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Create Medic shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Create Medic holding, its cost and its closing value.
How do I sell Create Medic and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.